Anti-viralAgents →↑↓ Flashcards
→↑↓ (42 cards)
**Life cycle of Virus
Viruses Hijack Our Cells
Viruses are intracellular parasites
Live and replicate inside other living cells
Depends on the synthetic processes of the host cells
Different virus have different host cells
Influenza Viruses
HSV
HIV virus
Influenza virus
Hemagglutinin HA
Neuraminidase NA
HA promotes binding and entry
NA allows budding and release
HSV
Glycoprotein gB gC
Cell surface proteoglycans (Heparan sulfate)
Glycoproteins gD of HSV bind to TNF NGF family protein receptor
MEmbrane fusion and viral penetration
HIV
CD4 receptor binding
co-receptor binding
Conformational change in gp120 Gp41 can initiate fusion
Replication of genetic materials& integration to the host genome
DNAvirus→enter cell as viral RNA → Viral DNA → integrated viral DNA between target site duplication
Budding
Release
Budding out (host cells intact
lysis of host cell
Types of Herpes Virus Infections-life long infection
Cytomegalovirus Disease and Retinitis
caused by
cytomegalovirus
Genital herpes infection
caused by herpes simplex virus
Herpes zoster
caused by varicella-zoster virus
Herpes zoster infection
caused by varicella-zoster virus
Highlycontagious
Most children are infected by early age
First exposure: Chickenpox
Latent infections: nerve cells(dorsal ganglion)
Reactivation: Shingles
Vaccine is available (MMRV)
Drugs for Herpes Virus Infection (Nucleoside analogs)
Inhibiting DNA/RNA Synthesis
Mechanism, Route of Acyclovir
is a guanine analog
Mechanism of actions:
- Competitive substrate for DNA polymerase.
- Leads to chain termination
Acyclovir has to be activated by thymidine kinase (only in infected cell) to form acyclovir triphosphate.
Intravenous (IV) preparation
Used for treatment of serious infections.
Oral preparation –Effective in treating primary infections. Less effective in treating recurrences.
Topical preparation –Keep an outbreak contained to a small area. (Treatment for cold sore on mouth)
Long term prophylaxis –Decreases the frequency of recurrences of genital herpes. (can be re-activated by strong sunlight, stress….etc.)
Toxicity: (oral) GI distress, headache.
Acyclovir and its derivatives
Valacyclovir Famciclovir Canciclovir Valganiclovir Trifluridine Idoxuridine Vidarabine
Drugs for Herpes virus infections (Inhibiting viral entry)
Docosanol
Prevents vira lentry, inhibits fusion between HSV envelop and plasma membranes.
Structure and classification Influenza (Flu)
Caused by enveloped RNA viruses.
- Influenza A
- Influenza B
- Influenza C
Classified based on NP, M1 and M2 proteins
Nomenclature of Influenza A
Divided into 18 H (H1-H18) and 11 N (N1-N11) subtypes.
Potentially 198 different subtypes of influenza A viruses.
Only viruses of the H1N1, H1N2, H3N2, H5N1, H7N3, H7N7, H9N2 have expanded their host to humans.
Reason Emergence of new strains
Natural Reservoir –large variety of species (chickens, birds, ducks, pigs and humans).
Animal to human transmission.
Re-assortment of the segmented genome of 2 parent viruses.
Mutation occurs at high rate (especially on the surface glycoproteins).
New variant is able to escape the host defense (vaccinated or not vaccinated).
Influenza B and C
Influenza B
Not divided into subtypes.
Type B flu is found only in humans and seals.
This limited host limits the generation of new strains by re-assortment.
Mutate at a rate 2 to 3 times lower than A viruses.
Do not cause pandemics.
Influenza C
Found in humans
People generally do not become very ill from the influenza type C viruses
Transmission and symptoms of Influenza
Nasal secretions
Aerosols containing the virus
Direct contact with bird droppings
Contact with contaminated surfaces
Usually recover in 2-7 days
Causes serious respiratory illness (hospitalization and death) in weak/frail or elderly people
Flu can be distinguished by a high fever with a sudden onset and extreme fatigue (usually more severe)
Antiviral drugs are effective in treating influenza
Only if given at early stage of infection
Mechanism of Entry of Influenza cells
Hemagglutinin (HA) –involved in the binding of the virus to host cell receptors
Neuraminidase–concerned with release of progeny virions from the cell surface.
Drugs for Influenza Virus Infection (Amantadine / Rimantadine)
Amantadine / Rimantadine
Prevention or treatment of influenza A infection only
Should be given within 48 hrs after contact.
- Block pore formation by M2 proteins of influenza A only
- Prevents H+ions from entering the virus.
- Prevents acidification of the virus core, which is required to active viral RNA transcriptase.
Toxic effects: GI irritation, dizziness, ataxia, slurred speech.
Oseltamivir(Tamiflu) / Zanamivir
Effective for influenza A or B infection
Resistance are increasing
More effective if used within 24 hrs(Five-day therapy)
MoA
- Binds to Influenza neuraminidase
- Prevents the cleavage of sialic acid residues
- Inability to release progeny virions
Prevent the spread of virus after it reproduces !
Peramivir
First FDA-approved IV drug of influenza in Dec 2014
Neuraminidase inhibitor
Effective against both influenza A and B viruses.
Administrated intravenously
Intended to be given in a single dose.
For patients who have difficulty with inhaled or oral medicines.
Common side effects:
Diarrhea, in less than 2% of patients.
Rare side effects:
Stevens-Johnson syndrome
and erythema multiforme
Baloxavir (Xofluza; PA endonuclease inhibitor):
Effective against influenza A & B virus
Administered in a single dose
Significantly shorten the duration of flu symptoms
Inhibits polymerase acidic endonuclease, thus impairs mRNA synthesis and prevents virus to reproduce
Structure and Types and Properties of Human Immunodeficiency Virus (HIV)
Is a retrovirus
HIV-1 (America)
HIV-2 (Africa)
HIV Latency: Many years before causing any symptoms.
- transmit it to others through their blood and bodily fluids
- develop into AIDS
- eventually weakens the immune system, that the patient may die of rare infections that would never be a problem for a healthy person
HIV virus is designed for fast evolution because it makes a lot of mutations when copying its own genome to make new virus particles (No proof read mechanism)
Thus, the viruses in an infected person’s body are constantly changing, which helps HIV become resistant both to the immune system and to the drugs that are used to treat it.
HIV infections must always be treated with a combination of drugs, so that if a virus arises that is resistant to one drug, it is most likely still susceptible to the other drugs in the treatment regimen
Combinations of drugs is the cocktail treatment
Highly active anti-retroviral therapy (HAART)
MoA of HIV Infection
Mostly infectsCD4+cells (alsocalled T-lymphocytes).
Destruction of CD4+cells impairs the immune system resulting in an increase risk of opportunistic infections.
Progression of HIV infection to acquired immunodeficiency syndrome(AIDS) occur in four phases:
Influenza-like symptoms
Virus undergoes rapid replication
Dramatic decline of CD4+ in viral replication
Immune system is damaged Viral production increase.
Drug for Attachment inhibitor of HIV:
Rukobia (Fostemsavir)
Phosphonooxymethylprodrug of temsavir
Temsavir binds and inhibits the activity of gp120, a subunit within the HIV-1 gp160 envelope glycoprotein that facilitates the attachment of HIV-1 to host cell CD4 receptors
Side effect: May induce ALT and AST levels in patients with Hep B or C, Nausea.